Complex Karyotype but Not Blast Percentage Is Associated with Poor Survival in Acute Myeloid Leukemia and Myelodysplastic Syndrome with Inv(3)(q21q26.2)/t(3;3)(q21;q26.2); a Bone Marrow Pathology Group Study

被引：0
|
作者：
Rogers, H. J.
Vardiman, J. W.
Anastasi, J.
Raca, G.
Savage, N. M.
Cherry, A. M.
Arber, D.
Moore, E.
Morrissette, J. J. D.
Bagg, A.
Liu, Y-C
Mathew, S.
Orazi, A.
Lin, P.
Wang, S. A.
Bueso-Ramos, C. E.
Foucar, K.
Hasserjian, R. P.
Hsi, E. D.
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Stanford Univ, Stanford, CA 94305 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Univ New Mexico, Albuquerque, NM 87131 USA
[8] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1498
引用
收藏
页码：358A / 358A
页数：1
相关论文
共 50 条
  • [21] Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia: A study of 6,515 cases of AML
    Groeschel, S.
    Lugthart, S.
    Beverloo, B. H.
    Kayser, S.
    Valk, P. J.
    Van Zelderen-Bhola, S. L.
    Ossenkoppele, G-J
    Vellenga, E.
    van den Berg-de Ruiter, E.
    Schanz, U.
    Verhoef, G.
    Ferrant, A.
    Koehne, C-H
    Pfreundschuh, M.
    Horst, H-A
    Koller, E.
    von Lilienfeld-Toal, M.
    Bentz, M.
    Ganser, A.
    Schlegelberger, B.
    Jotterand, M.
    Krauter, J.
    Pabst, T.
    Theobald, M.
    Schlenk, R. F.
    Delwel, R.
    Doehner, K.
    Lowenberg, B.
    Doehner, H.
    ONKOLOGIE, 2010, 33 : 6 - 6
  • [22] The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2)
    Wang, Huan-You
    Rashidi, Hooman H.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (12) : 1404 - 1410
  • [23] A STUDY ON THE CLINICAL SIGNIFICANCE OF THE WHO AML SUBTYPE INV(3)(Q21Q26.2)/T(3;3)(Q21;Q26.2) AND VARIOUS OTHER 3Q CHROMOSOMAL ABNORMALITIES IN 6,819 AML CASES
    Lugthart, S.
    Groeschel, S.
    Beverloo, H.
    Valk, P.
    Schanz, U.
    Bhola, S.
    Vellenga, E.
    Kayser, S.
    Ossenkoppele, G.
    Verhoef, G.
    Ferrant, A.
    van den Berg-de Ruiter, E.
    Ganser, A.
    Jotterand, M.
    Krauter, J.
    Pabst, T.
    Schlegelberger, B.
    Schlenk, R.
    Delwel, R.
    Doehner, K.
    Loewenberg, B.
    Doehner, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 482 - 482
  • [24] Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols
    Sitges, Marta
    Boluda, Blanca
    Garrido, Ana
    Morgades, Mireia
    Granada, Isabel
    Barragan, Eva
    Arnan, Montserrat
    Serrano, Josefina
    Tormo, Mar
    Miguel Bergua, Juan
    Colorado, Mercedes
    Salamero, Olga
    Esteve, Jordi
    Benavente, Celina
    Perez-Encinas, Manuel
    Coll, Rosa
    Marti-Tutusaus, Josep-Maria
    Brunet, Salut
    Sierra, Jorge
    angel Sanz, Miguel
    Montesinos, Pau
    Ribera, Josep-Maria
    Vives, Susana
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (02) : 138 - 147
  • [25] Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: A case report
    Lewen M.
    Gresh R.
    Queenan M.
    Paessler M.
    Pillai V.
    Hexner E.
    Frank D.
    Bagg A.
    Aplenc R.
    Caywood E.
    Wertheim G.
    Biomarker Research, 4 (1)
  • [26] Myelodysplastic Syndrome/Acute Myeloid Leukemia With t(3;21)(q26.2;q22) Is Commonly a Therapy-Related Disease Associated With Poor Outcome
    Li, Shaoying
    Yin, C. Cameron
    Medeiros, L. Jeffrey
    Bueso-Ramos, Carlos
    Lu, Gary
    Lin, Pei
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (01) : 146 - 152
  • [27] Molecular and pathologic characterization of AML with double Inv(3)(q21q26.2)
    Hodge, Jennelle C.
    Bosler, David
    Rubinstein, Lauren
    Sadri, Navid
    Shetty, Shashirekha
    CANCER GENETICS, 2019, 230 : 28 - 36
  • [28] Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression
    Jun Gu
    Keyur P. Patel
    Bing Bai
    Ching-Hua Liu
    Guilin Tang
    Hagop M. Kantarjian
    Zhenya Tang
    Ronald Abraham
    Rajyalakshmi Luthra
    L. Jeffrey Medeiros
    Pei Lin
    Xinyan Lu
    Molecular Cytogenetics, 8
  • [29] Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression
    Gu, Jun
    Patel, Keyur P.
    Bai, Bing
    Liu, Ching-Hua
    Tang, Guilin
    Kantarjian, Hagop M.
    Tang, Zhenya
    Abraham, Ronald
    Luthra, Rajyalakshmi
    Medeiros, L. Jeffrey
    Lin, Pei
    Lu, Xinyan
    MOLECULAR CYTOGENETICS, 2015, 8
  • [30] Lenalidomide Plus Hypomethylating Agent for Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities -AML with Inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, Mecom
    Merz, Lauren E.
    Perissinotti, Anthony J.
    Marini, Bernard Lawrence
    Crouch, Ashley
    Pettit, Kristen
    Burke, Patrick W.
    Erba, Harry P.
    Bixby, Dale L.
    BLOOD, 2018, 132
12345